Analysts Are Bullish on These Healthcare Stocks: Raffles Medical Group (RAFLF), Evolent Health (EVH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Raffles Medical Group (RAFLFResearch Report) and Evolent Health (EVHResearch Report) with bullish sentiments.

Raffles Medical Group (RAFLF)

In a report released today, Llelleythan Tan from UOB Kay Hian maintained a Buy rating on Raffles Medical Group, with a price target of S$1.90. The company’s shares closed last Monday at $1.08, equals to its 52-week high of $1.08.

According to TipRanks.com, Tan is ranked #6838 out of 8414 analysts.

Currently, the analyst consensus on Raffles Medical Group is a Strong Buy with an average price target of $1.39, implying a 28.7% upside from current levels. In a report issued on June 8, RHB Capital also maintained a Buy rating on the stock with a S$1.75 price target.

See today’s best-performing stocks on TipRanks >>

Evolent Health (EVH)

In a report released yesterday, David Larsen from BTIG reiterated a Buy rating on Evolent Health, with a price target of $45.00. The company’s shares closed last Friday at $28.86.

According to TipRanks.com, Larsen is ranked 0 out of 5 stars with an average return of -9.5% and a 35.0% success rate. Larsen covers the Healthcare sector, focusing on stocks such as Privia Health Group, Oak Street Health, and Simulations Plus.

Currently, the analyst consensus on Evolent Health is a Strong Buy with an average price target of $44.00, a 45.9% upside from current levels. In a report issued on May 31, J.P. Morgan also maintained a Buy rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.